Blog

Better lung cancer treatment? Immunotherapy drug Keytruda boosts effectiveness of chemotherapy in trial – Genetic Literacy Project


Genetic Literacy Project

Better lung cancer treatment? Immunotherapy drug Keytruda boosts effectiveness of chemotherapy in trial
Genetic Literacy Project
A widely used immunotherapy drug appears to be useful in a greater number of patients with lung cancer. The drug called Keytruda, or pembrolizumab, is already prescribed to a group of patients who have a type of malignancy called non-small cell lung
'This is not experimental anymore': How immunotherapy is being used for some lung cancer and melanoma patientsCBC.ca


New hope for stage 4 lung cancer patientsFoster’s Daily Democrat

all 3 news articles »

2018-04-26 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.